Cefepime sodium injection

Product Details
img
Name Of Product(Genric Name) :

Cefepime sodium injection

Dosage :

250MG/500MG/1GM

Product Description :

CEFEPIME SODIUM INJECTION
250 mg / 500 mg / 1 g

Sterile Powder for Solution for Intravenous or Intramuscular Administration

  1. COMPOSITION

Each vial contains:

Cefepime Sodium equivalent to Cefepime ............... 250 mg

or

Cefepime Sodium equivalent to Cefepime ............... 500 mg

or

Cefepime Sodium equivalent to Cefepime ............... 1 g

Excipients: As applicable.

  1. PHARMACEUTICAL FORM

Sterile, white to off-white powder for solution for intravenous or intramuscular administration.

  1. THERAPEUTIC CLASS

Fourth-Generation Cephalosporin Antibiotic

  1. INDICATIONS

Cefepime Sodium Injection is indicated for the treatment of moderate to severe bacterial infections caused by susceptible microorganisms.

It may be used in the treatment of:

• Lower respiratory tract infections
• Complicated urinary tract infections
• Intra-abdominal infections
• Skin and soft-tissue infections
• Bone and joint infections
• Septicemia and bloodstream infections
• Febrile neutropenia with suspected bacterial infection
• Serious infections caused by susceptible Pseudomonas aeruginosa
• Other severe bacterial infections caused by susceptible microorganisms

Treatment should be guided by the susceptibility of the causative organism and applicable antimicrobial guidelines.

  1. CONTRAINDICATIONS

Cefepime Sodium is contraindicated in patients with known hypersensitivity to cefepime, other cephalosporins, penicillins, or any component of the formulation.

  1. DRUG INTERACTIONS

Particular consideration may be required with concomitant use of:

• Aminoglycoside antibiotics
• Other nephrotoxic medicines
• Potent diuretics
• Other β-lactam antibiotics
• Anticoagulants such as warfarin

The treating physician should review all concomitant medications before administration.

  1. ADMINISTRATION

Cefepime Sodium Injection may be administered by intravenous or intramuscular route according to the approved product information.

The contents of the vial should be reconstituted with a suitable compatible diluent under appropriate aseptic conditions.

For intravenous administration, the reconstituted solution should be further diluted as required and administered by a qualified healthcare professional according to the approved product information and institutional protocol.

For Intravenous or Intramuscular Use Only.

  1. STORAGE

Store according to the storage conditions stated on the approved product label.

Protect from excessive heat, moisture and light.


Dry Powder Injection